Radiopharmaceuticals: US FDA Guidance Allows Some Flexibility For Burgeoning Drug Class

 
• By Manas Mishra
  
Team Of Medical Research Scientists Collectively Working
The draft guidance arrives as the number of radiopharmaceutical therapy trials grows. (Shutterstock)

More from Clinical Trials

More from R&D